abstract |
Compositions and methods for targeted treatment of cancers, such as TLR9-expressing cancers, are disclosed. In particular, molecules containing TLR9 targeting ligands (eg, CpG oligodeoxynucleotides) are disclosed that target lytic peptides to TLR9-expressing malignant cells. |